Global Hereditary Angioedema Drug Market Research Report 2025(Status and Outlook)

March 2025 | 214 pages | ID: G3FF1EEF3557EN
Bosson Research

Abstracts

Report Overview

In the past 2 years, the FDA has approved 3 new drugs for prevention or treatment of hereditary angioedema (HAE) in non-pregnant adolescents and adults: the C1 esterase inhibitor Cinryze for prophylaxis and the C1 esterase inhibitor Berinert and the kallikrein inhibitor ecallantide (Kalbitor) for treatment of acute attacks.

This report provides a deep insight into the global Hereditary Angioedema Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hereditary Angioedema Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hereditary Angioedema Drug market in any manner.

Global Hereditary Angioedema Drug Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Pharming Group NV

Takeda

CSL Limited

IBio Inc.

BioCryst Pharmaceuticals

Inc.

Ionis Pharmaceuticals

Inc.

Market Segmentation (by Type)

C1 Esterase Inhibitor

Kallikrein Inhibitor

Selective Bradykinin B2 Receptor Antagonist

Market Segmentation (by Application)

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Hereditary Angioedema Drug Market
• Overview of the regional outlook of the Hereditary Angioedema Drug Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Angioedema Drug Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hereditary Angioedema Drug
1.2 Key Market Segments
1.2.1 Hereditary Angioedema Drug Segment by Type
1.2.2 Hereditary Angioedema Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Hereditary Angioedema Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Hereditary Angioedema Drug Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Hereditary Angioedema Drug Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Hereditary Angioedema Drug Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Hereditary Angioedema Drug Product Life Cycle
3.3 Global Hereditary Angioedema Drug Sales by Manufacturers (2020-2025)
3.4 Global Hereditary Angioedema Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hereditary Angioedema Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Hereditary Angioedema Drug Manufacturing Sites, Area Served, Product Type
3.8 Hereditary Angioedema Drug Market Competitive Situation and Trends
3.8.1 Hereditary Angioedema Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hereditary Angioedema Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Hereditary Angioedema Drug Industry Chain Analysis
4.1 Hereditary Angioedema Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hereditary Angioedema Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hereditary Angioedema Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Hereditary Angioedema Drug Market
5.7 ESG Ratings of Leading Companies
6 Global Hereditary Angioedema Drug Market by Region
6.1 Global Hereditary Angioedema Drug Market Size by Region
6.1.1 Global Hereditary Angioedema Drug Market Size by Region
6.1.2 Global Hereditary Angioedema Drug Market Size Market Share by Region
6.2 Global Hereditary Angioedema Drug Sales by Region
6.2.1 Global Hereditary Angioedema Drug Sales by Region
6.2.2 Global Hereditary Angioedema Drug Sales Market Share by Region
7 North America Market Overview
7.1 North America Hereditary Angioedema Drug Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Hereditary Angioedema Drug Market Size by Type
7.3 North America Hereditary Angioedema Drug Market Size by Application
8 Europe Market Overview
8.1 Europe Hereditary Angioedema Drug Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Hereditary Angioedema Drug Market Size by Type
8.3 Europe Hereditary Angioedema Drug Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Hereditary Angioedema Drug Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Hereditary Angioedema Drug Market Size by Type
9.3 Asia-Pacific Hereditary Angioedema Drug Market Size by Application
10 South America Market Overview
10.1 South America Hereditary Angioedema Drug Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Hereditary Angioedema Drug Market Size by Type
10.3 South America Hereditary Angioedema Drug Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Hereditary Angioedema Drug Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Hereditary Angioedema Drug Market Size by Type
11.3 Middle East and Africa Hereditary Angioedema Drug Market Size by Application
12 Hereditary Angioedema Drug Market Production by Region
12.1 Global Production of Hereditary Angioedema Drug by Region(2020-2025)
12.2 Global Hereditary Angioedema Drug Revenue Market Share by Region (2020-2025)
12.3 Global Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Hereditary Angioedema Drug Production
12.4.1 North America Hereditary Angioedema Drug Production Growth Rate (2020-2025)
12.4.2 North America Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Hereditary Angioedema Drug Production
12.5.1 Europe Hereditary Angioedema Drug Production Growth Rate (2020-2025)
12.5.2 Europe Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Hereditary Angioedema Drug Production (2020-2025)
12.6.1 Japan Hereditary Angioedema Drug Production Growth Rate (2020-2025)
12.6.2 Japan Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Hereditary Angioedema Drug Production (2020-2025)
12.7.1 China Hereditary Angioedema Drug Production Growth Rate (2020-2025)
12.7.2 China Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2020-2025)
13 Hereditary Angioedema Drug Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Hereditary Angioedema Drug Sales Market Share by Type (2020-2033)
13.3 Global Hereditary Angioedema Drug Market Size Market Share by Type (2020-2033)
13.4 Global Hereditary Angioedema Drug Price by Type (2020-2033)
14 Hereditary Angioedema Drug Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Hereditary Angioedema Drug Market Sales by Application (2020-2033)
14.3 Global Hereditary Angioedema Drug Market Size (M USD) by Application (2020-2033)
14.4 Global Hereditary Angioedema Drug Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Pharming Group NV
15.1.1 Pharming Group NV Basic Information
15.1.2 Pharming Group NV Hereditary Angioedema Drug Product Overview
15.1.3 Pharming Group NV Hereditary Angioedema Drug Product Market Performance
15.1.4 Pharming Group NV Business Overview
15.1.5 Pharming Group NV SWOT Analysis
15.1.6 Pharming Group NV Recent Developments
15.2 Takeda
15.2.1 Takeda Basic Information
15.2.2 Takeda Hereditary Angioedema Drug Product Overview
15.2.3 Takeda Hereditary Angioedema Drug Product Market Performance
15.2.4 Takeda Business Overview
15.2.5 Takeda SWOT Analysis
15.2.6 Takeda Recent Developments
15.3 CSL Limited
15.3.1 CSL Limited Basic Information
15.3.2 CSL Limited Hereditary Angioedema Drug Product Overview
15.3.3 CSL Limited Hereditary Angioedema Drug Product Market Performance
15.3.4 CSL Limited Business Overview
15.3.5 CSL Limited SWOT Analysis
15.3.6 CSL Limited Recent Developments
15.4 IBio Inc.
15.4.1 IBio Inc. Basic Information
15.4.2 IBio Inc. Hereditary Angioedema Drug Product Overview
15.4.3 IBio Inc. Hereditary Angioedema Drug Product Market Performance
15.4.4 IBio Inc. Business Overview
15.4.5 IBio Inc. Recent Developments
15.5 BioCryst Pharmaceuticals
15.5.1 BioCryst Pharmaceuticals Basic Information
15.5.2 BioCryst Pharmaceuticals Hereditary Angioedema Drug Product Overview
15.5.3 BioCryst Pharmaceuticals Hereditary Angioedema Drug Product Market Performance
15.5.4 BioCryst Pharmaceuticals Business Overview
15.5.5 BioCryst Pharmaceuticals Recent Developments
15.6 Inc.
15.6.1 Inc. Basic Information
15.6.2 Inc. Hereditary Angioedema Drug Product Overview
15.6.3 Inc. Hereditary Angioedema Drug Product Market Performance
15.6.4 Inc. Business Overview
15.6.5 Inc. Recent Developments
15.7 Ionis Pharmaceuticals
15.7.1 Ionis Pharmaceuticals Basic Information
15.7.2 Ionis Pharmaceuticals Hereditary Angioedema Drug Product Overview
15.7.3 Ionis Pharmaceuticals Hereditary Angioedema Drug Product Market Performance
15.7.4 Ionis Pharmaceuticals Business Overview
15.7.5 Ionis Pharmaceuticals Recent Developments
15.8 Inc.
15.8.1 Inc. Basic Information
15.8.2 Inc. Hereditary Angioedema Drug Product Overview
15.8.3 Inc. Hereditary Angioedema Drug Product Market Performance
15.8.4 Inc. Business Overview
15.8.5 Inc. Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hereditary Angioedema Drug Market Size by Type (M USD)
Table 4. Global Hereditary Angioedema Drug Market Size by Application (M USD)
Table 5. Hereditary Angioedema Drug Market Size Comparison by Region (M USD)
Table 6. Global Hereditary Angioedema Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Hereditary Angioedema Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Hereditary Angioedema Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Hereditary Angioedema Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Drug as of 2024)
Table 11. Global Market Hereditary Angioedema Drug Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Hereditary Angioedema Drug Manufacturing Sites and Area Served
Table 13. Manufacturers Hereditary Angioedema Drug Product Type
Table 14. Global Hereditary Angioedema Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hereditary Angioedema Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Hereditary Angioedema Drug Market Size Comparison by Region (M USD)
Table 26. Global Hereditary Angioedema Drug Market Size by Region (2020-2033) & (M USD)
Table 27. Global Hereditary Angioedema Drug Market Size Market Share by Region (2020-2033)
Table 28. Global Hereditary Angioedema Drug Sales by Region (2020-2033) & (K MT)
Table 29. Global Hereditary Angioedema Drug Sales Market Share by Region (2020-2033)
Table 30. North America Hereditary Angioedema Drug Market Size by Country (2020-2033) & (M USD)
Table 31. North America Hereditary Angioedema Drug Sales by Country (2020-2033) & (K MT)
Table 32. North America Hereditary Angioedema Drug Sales by Type (K MT)
Table 33. North America Hereditary Angioedema Drug Market Size by Type (M USD)
Table 34. North America Hereditary Angioedema Drug Sales (K MT) by Type (2020-2033)
Table 35. North America Hereditary Angioedema Drug Market Size (M USD) by Type (2020-2033)
Table 36. North America Hereditary Angioedema Drug Sales by Application (K MT)
Table 37. North America Hereditary Angioedema Drug Market Size by Application (M USD)
Table 38. North America Hereditary Angioedema Drug Sales (K MT) by Application (2020-2033)
Table 39. North America Hereditary Angioedema Drug Market Size (M USD) by Application (2020-2033)
Table 40. Europe Hereditary Angioedema Drug Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Hereditary Angioedema Drug Sales by Country (2020-2033) & (K MT)
Table 42. Europe Hereditary Angioedema Drug Sales by Type (K MT)
Table 43. Europe Hereditary Angioedema Drug Market Size by Type (M USD)
Table 44. Europe Hereditary Angioedema Drug Sales (K MT) by Type (2020-2033)
Table 45. Europe Hereditary Angioedema Drug Market Size (M USD) by Type (2020-2033)
Table 46. Europe Hereditary Angioedema Drug Sales by Application (K MT)
Table 47. Europe Hereditary Angioedema Drug Market Size by Application (M USD)
Table 48. Europe Hereditary Angioedema Drug Sales (K MT) by Application (2020-2033)
Table 49. Europe Hereditary Angioedema Drug Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Hereditary Angioedema Drug Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Hereditary Angioedema Drug Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Hereditary Angioedema Drug Sales by Type (K MT)
Table 53. Asia-Pacific Hereditary Angioedema Drug Market Size by Type (M USD)
Table 54. Asia-Pacific Hereditary Angioedema Drug Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Hereditary Angioedema Drug Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Hereditary Angioedema Drug Sales by Application (K MT)
Table 57. Asia-Pacific Hereditary Angioedema Drug Market Size by Application (M USD)
Table 58. Asia-Pacific Hereditary Angioedema Drug Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Hereditary Angioedema Drug Market Size (M USD) by Application (2020-2025)
Table 60. South America Hereditary Angioedema Drug Market Size by Country (2020-2033) & (M USD)
Table 61. South America Hereditary Angioedema Drug Sales by Country (2020-2033) & (K MT)
Table 62. South America Hereditary Angioedema Drug Sales by Type (K MT)
Table 63. South America Hereditary Angioedema Drug Market Size by Type (M USD)
Table 64. South America Hereditary Angioedema Drug Sales (K MT) by Type (2020-2033)
Table 65. South America Hereditary Angioedema Drug Market Size (M USD) by Type (2020-2033)
Table 66. South America Hereditary Angioedema Drug Sales by Application (K MT)
Table 67. South America Hereditary Angioedema Drug Market Size by Application (M USD)
Table 68. South America Hereditary Angioedema Drug Sales (K MT) by Application (2020-2033)
Table 69. South America Hereditary Angioedema Drug Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Hereditary Angioedema Drug Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Hereditary Angioedema Drug Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Hereditary Angioedema Drug Sales by Type (K MT)
Table 73. Middle East and Africa Hereditary Angioedema Drug Market Size by Type (M USD)
Table 74. Middle East and Africa Hereditary Angioedema Drug Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Hereditary Angioedema Drug Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Hereditary Angioedema Drug Sales by Application (K MT)
Table 77. Middle East and Africa Hereditary Angioedema Drug Market Size by Application (M USD)
Table 78. Middle East and Africa Hereditary Angioedema Drug Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Hereditary Angioedema Drug Market Size (M USD) by Application (2020-2033)
Table 80. Global Hereditary Angioedema Drug Production (K MT) by Region(2020-2025)
Table 81. Global Hereditary Angioedema Drug Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Hereditary Angioedema Drug Revenue Market Share by Region (2020-2025)
Table 83. Global Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Hereditary Angioedema Drug Sales by Type (K MT)
Table 89. Global Hereditary Angioedema Drug Market Size by Type (M USD)
Table 90. Global Hereditary Angioedema Drug Sales (K MT) by Type (2020-2033)
Table 91. Global Hereditary Angioedema Drug Sales Market Share by Type (2020-2033)
Table 92. Global Hereditary Angioedema Drug Market Size (M USD) by Type (2020-2033)
Table 93. Global Hereditary Angioedema Drug Market Size Share by Type (2020-2033)
Table 94. Global Hereditary Angioedema Drug Sales (K MT) by Application
Table 95. Global Hereditary Angioedema Drug Market Size by Application(M USD)
Table 96. Global Hereditary Angioedema Drug Sales by Application (2020-2033) & (K MT)
Table 97. Global Hereditary Angioedema Drug Sales Market Share by Application (2020-2033)
Table 98. Global Hereditary Angioedema Drug Market Size by Application (2020-2033) & (M USD)
Table 99. Global Hereditary Angioedema Drug Market Share by Application (2020-2033)
Table 100. Global Hereditary Angioedema Drug Sales Growth Rate by Application (2020-2033)
Table 101. Pharming Group NV Basic Information
Table 102. Pharming Group NV Hereditary Angioedema Drug Product Overview
Table 103. Pharming Group NV Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Pharming Group NV Business Overview
Table 105. Pharming Group NV SWOT Analysis
Table 106. Pharming Group NV Recent Developments
Table 107. Takeda Basic Information
Table 108. Takeda Hereditary Angioedema Drug Product Overview
Table 109. Takeda Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Takeda Business Overview
Table 111. Takeda SWOT Analysis
Table 112. Takeda Recent Developments
Table 113. CSL Limited Basic Information
Table 114. CSL Limited Hereditary Angioedema Drug Product Overview
Table 115. CSL Limited Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. CSL Limited Business Overview
Table 117. CSL Limited SWOT Analysis
Table 118. CSL Limited Recent Developments
Table 119. IBio Inc. Basic Information
Table 120. IBio Inc. Hereditary Angioedema Drug Product Overview
Table 121. IBio Inc. Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. IBio Inc. Business Overview
Table 123. IBio Inc. Recent Developments
Table 124. BioCryst Pharmaceuticals Basic Information
Table 125. BioCryst Pharmaceuticals Hereditary Angioedema Drug Product Overview
Table 126. BioCryst Pharmaceuticals Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. BioCryst Pharmaceuticals Business Overview
Table 128. BioCryst Pharmaceuticals Recent Developments
Table 129. Inc. Basic Information
Table 130. Inc. Hereditary Angioedema Drug Product Overview
Table 131. Inc. Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Inc. Business Overview
Table 133. Inc. Recent Developments
Table 134. Ionis Pharmaceuticals Basic Information
Table 135. Ionis Pharmaceuticals Hereditary Angioedema Drug Product Overview
Table 136. Ionis Pharmaceuticals Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Ionis Pharmaceuticals Business Overview
Table 138. Ionis Pharmaceuticals Recent Developments
Table 139. Inc. Basic Information
Table 140. Inc. Hereditary Angioedema Drug Product Overview
Table 141. Inc. Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Inc. Business Overview
Table 143. Inc. Recent Developments
List of Figures
Figure 1. Product Picture of Hereditary Angioedema Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Angioedema Drug Market Size (M USD), 2024-2033
Figure 5. Global Hereditary Angioedema Drug Market Size (M USD) (2020-2033)
Figure 6. Global Hereditary Angioedema Drug Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Angioedema Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hereditary Angioedema Drug Product Life Cycle
Figure 13. Hereditary Angioedema Drug Sales Share by Manufacturers in 2024
Figure 14. Global Hereditary Angioedema Drug Revenue Share by Manufacturers in 2024
Figure 15. Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Hereditary Angioedema Drug Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hereditary Angioedema Drug Revenue in 2024
Figure 18. Industry Chain Map of Hereditary Angioedema Drug
Figure 19. Global Hereditary Angioedema Drug Market PEST Analysis
Figure 20. Global Hereditary Angioedema Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Hereditary Angioedema Drug Market Size by Region
Figure 27. Global Hereditary Angioedema Drug Market Size Market Share by Region (2020-2033)
Figure 28. Global Hereditary Angioedema Drug Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Hereditary Angioedema Drug Market Size (M USD) by Country
Figure 33. USA Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Hereditary Angioedema Drug Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Hereditary Angioedema Drug Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Hereditary Angioedema Drug Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Hereditary Angioedema Drug Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Hereditary Angioedema Drug Market Size (M USD)by Type
Figure 40. North America Hereditary Angioedema Drug Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Hereditary Angioedema Drug Market Size (M USD) by Country
Figure 45. Germany Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Hereditary Angioedema Drug Market Size (M USD) by Type
Figure 56. Europe Hereditary Angioedema Drug Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Hereditary Angioedema Drug Market Size (M USD) by Country
Figure 61. China Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Hereditary Angioedema Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Hereditary Angioedema Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Hereditary Angioedema Drug Market Size (M USD) by Type
Figure 72. Asia-Pacific Hereditary Angioedema Drug Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Hereditary Angioedema Drug Market Size (M USD) by Country
Figure 77. Brazil Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Hereditary Angioedema Drug Market Size (M USD) by Type
Figure 84. South America Hereditary Angioedema Drug Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Hereditary Angioedema Drug Market Size (M USD) by Country
Figure 89. Saudi Arabia Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Hereditary Angioedema Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Hereditary Angioedema Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Hereditary Angioedema Drug Market Size (M USD) by Type
Figure 100. Middle East and Africa Hereditary Angioedema Drug Market Size (M USD) by Application
Figure 101. Global Hereditary Angioedema Drug Production Market Share by Region (2020-2025)
Figure 102. North America Hereditary Angioedema Drug Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Hereditary Angioedema Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Hereditary Angioedema Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. China Hereditary Angioedema Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Hereditary Angioedema Drug Market Size by Type (M USD)
Figure 108. Sales Market Share of Hereditary Angioedema Drug by Type (2020-2033)
Figure 109. Sales Market Share of Hereditary Angioedema Drug by Type in 2024
Figure 110. Market Size Share of Hereditary Angioedema Drug by Type (2020-2033)
Figure 111. Market Size Share of Hereditary Angioedema Drug by Type in 2024
Figure 112. Global Hereditary Angioedema Drug Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Hereditary Angioedema Drug Market Size by Application(M USD)
Figure 115. Global Hereditary Angioedema Drug Market Share by Application
Figure 116. Global Hereditary Angioedema Drug Sales Market Share by Application (2020-2033)
Figure 117. Global Hereditary Angioedema Drug Sales Market Share by Application in 2024
Figure 118. Global Hereditary Angioedema Drug Market Share by Application (2020-2033)
Figure 119. Global Hereditary Angioedema Drug Market Share by Application in 2024
Figure 120. Global Hereditary Angioedema Drug Sales Growth Rate by Application (2020-2033)